55 Results for "

398

" in MedChemExpress (MCE) Product Catalog:
Products (55)

55 Results for "398" in MCE Product Catalog:

48
48 Publications Verification
Cat. No.: HY-13311
CAS No.: 872511-34-7
Purity:  99.82%
Synonyms: BGJ-398; NVP-BGJ398
Target:  

FGFR Apoptosis

Research Areas:  

Cancer

Infigratinib (BGJ-398; NVP-BGJ398) is a potent inhibitor of the FGFR family with IC50s of 0.9 nM, 1.4 nM, 1 nM, and 60 nM for FGFR1, FGFR2, FGFR3, and FGFR4, respectively.
loading...
    loading...
48
48 Publications Verification
Cat. No.: HY-13311A
CAS No.: 1310746-10-1
Purity:  99.59%
Synonyms: BGJ-398 phosphate; NVP-BGJ398 phosphate
Target:  

FGFR

Research Areas:  

Cancer

Infigratinib phosphate (BGJ-398 phosphate; NVP-BGJ398 phosphate) is a potent inhibitor of the FGFR family with IC50 of 0.9 nM, 1.4 nM, 1 nM, and 60 nM for FGFR1, FGFR2, FGFR3, and FGFR4, respectively.
loading...
    loading...
21
21 Cited Publications
Cat. No.: HY-13913
CAS No.: 123653-11-2
Purity:  99.71%
Target:  

COX

Research Areas:  

Inflammation/Immunology Cancer

NS-398 is a non-steroidal an-inflammatory agent with analgesic and antipyretic effects, and selectively inhibits prostaglandin G/H synthase 2/cyclooxygenase 2 (COX-2) activity, with an IC50 of 3.8 μM, and has no effect on COX-1 at 100 μM.
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-10424
CAS No.: 802539-81-7
Purity:  99.90%
Synonyms: PHA-848125
Target:  

CDK Autophagy

Research Areas:  

Cancer

Milciclib (PHA-848125) is a potent, ATP-competitive and dual inhibitor of CDK and Tropomyosin receptor kinase (TRK), with IC50s of 45, 150, 160, 363, 398 nM and 53 nM for cyclin A/CDK2, cyclin H/CDK7, cyclin D1/CDK4, cyclin E/CDK2, cyclin B/CDK1 and TRKA, respectively.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-101395
CAS No.: 909725-61-7
Purity:  99.83%
Target:  

LPL Receptor Apoptosis

Research Areas:  

Metabolic Disease Cancer

W146 is a selective antagonist of sphingosine-1-phosphate receptor 1 (S1PR1) with an EC50 value of 398 nM.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-101395A
CAS No.: 909725-62-8
Purity:  98.22%
Target:  

LPL Receptor Apoptosis

Research Areas:  

Metabolic Disease Cancer

W146 TFA is a selective antagonist of sphingosine-1-phosphate receptor 1 (S1PR1) with an EC50 value of 398 nM.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-14858
CAS No.: 251945-92-3
Purity:  99.93%
Synonyms: SLV 320
Target:  

Adenosine Receptor

Research Areas:  

Cardiovascular Disease

Derenofylline (SLV 320) is a potent, selective and orally active adenosine A1 receptor antagonist, with Ki values of 1 nM, 200 nM and 398 nM for human A1, A3 and A2A receptors respectively. Derenofylline suppresses cardiac fibrosis and attenuates albuminuria without affecting blood pressure in rats .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-103416
CAS No.: 145307-34-2
Purity:  ≥98.0%
Target:  

Dopamine Receptor

Research Areas:  

Neurological Disease

A-77636 hydrochloride is a potent, orally active, selective and long acting dopamine D1 receptor agonist (pKi=7.40; Ki=39.8 nM) with antiparkinsonian activity. A-77636 hydrochloride is functionally inactive at dopamine D2 receptor .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-125527A
CAS No.: 528583-91-7
Purity:  99.1%
Synonyms: 17(R)-RvD1; AT-RvD1
Target:  

TRP Channel

Research Areas:  

Inflammation/Immunology

17R-Resolvin D1 (17R-RvD1; AT-RvD1) is an aspirin-triggered epimer of Resolvin D1, which exhibits anti-inflammatory activity in mice and human PMNs cells . 17R-Resolvin D1 specificially inhibits TRPV3 with an IC50 of 398 nM and exhibits peripheral anti-nociceptive efficacy .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-152226
CAS No.: 2284460-01-9
Purity:  98.71%
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

MC2590 is a potent pyridine-containing histone deacetylase (HDAC) inhibitor. MC2590 is a inhibitor of HDAC1-3, -6, -8, and -10 (class I/IIb-selective inhibitor) with IC50s of 0.015 μM-0.156 μM. MC2590 also inhibits HDAC isoforms HDAC4, HDAC5, HDAC7, HDAC9, HDAC11 with IC50s of 1.35 μM-3.98 μM. MC2625 induces G2/M cell cycle arrest and modulates pro- and anti-apoptotic microRNAs towards apoptosis induction .
loading...
    loading...
Cat. No.: HY-145628
CAS No.: 1121931-70-1
Purity:  99.85%
CM398 is a highly selective, orally active Sigma-2 receptor ligand with a Ki value of 0.43 nM. CM398 ameliorates age-related macular degeneration. CM398 exerts analgesic effects on visceral pain, inflammatory pain and neuropathic pain. CM398 can be used in research related to age-related macular degeneration, neuropathic pain and inflammatory pain .
loading...
    loading...
Cat. No.: HY-174369
Target:  

TREM receptor Syk

Research Areas:  

Neurological Disease

TREM2 agonist-3 (Compound 4i) is a TREM2 agonist with a KD value of 19.0 µM. The KD value of TREM2 agonist-3 for TREM1 is 39.8 µM. TREM2 agonist-3 induces an increase in phosphorylated SYK levels. TREM2 agonist-3 can be used in the research of neurodegenerative diseases and other diseases associated with TREM2 dysfunction .
loading...
    loading...
Cat. No.: HY-175232
CAS No.: 488801-10-1
GL64 is a selective agonist of ADGRD1 (EC50 = 3.98 μM). GL64 has low selectivity for ADGRD2, ADGRG5, ADGRG6, CELSR1, CELSR2, CELSR3, and ADGRG4 isoforms. GL64 activates ADGRD1 by mimicking the satchel sequence. GL64 regulates osteoclast maturation through the cAMP-PKA-NFATC1 pathway. GL64 effectively inhibits osteoclastogenesis and prevents bone loss both in vitro and in vivo. GL64 is useful in the study of osteoclast-related diseases .
loading...
    loading...
Cat. No.: HY-103595
CAS No.: 18694-40-1
Purity:  99.86%
Synonyms: Mepirizole; DA-398
Target:  

Drug Derivative

Research Areas:  

Inflammation/Immunology

Epirizole (Mepirizole) is an orally active NSAID (nonsteroidal anti-inflammatory agent). Epirizole shows anti-inflammatory activity, and can be used in chronic rheumatoid arthritis research .
loading...
    loading...
Cat. No.: HY-149843
CAS No.: 2828438-38-4
Purity:  99.23%
Target:  

PROTACs FGFR

Research Areas:  

Cancer

LC-MB12 is an orally active PROTAC compound targets FGFR2 degradation with a DC50 of 11.8 nM. LC-MB12 contains BGJ398 (a FGFR2 inhibitor), PROTAC linker and CRBN.LC-MB12 inhibits FGFR2 signaling in gastric cancer cells and has anti-tumor activity .
loading...
    loading...
Cat. No.: HY-110109
CAS No.: 1198357-79-7
Purity:  98.97%
Target:  

PI3K DNA-PK mTOR

Research Areas:  

Cancer

ETP-45658 is a potent PI3K inhibitor, with IC50s of 22.0 nM, 39.8 nM, 129.0 nM and 717.3 nM for PI3Kα, PI3Kδ, PI3Kβ and PI3Kγ, respectively. ETP-45658 also can inhibit DNA-PK (IC50=70.6 nM) and mTOR (IC50=152.0 nM). ETP-45658 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-14362
CAS No.: 874119-56-9
Purity:  99.68%
Research Areas:  

Cardiovascular Disease

GSK-25 is a potent, selective and orally bioavailable ROCK1 inhibitor (IC50=7 nM). GSK-25 maintains good selectivity against a panel of 31 kinases (>100 fold), as well as RSK1 and p70S6K (RSK1: IC50=398 nM, p70S6K: IC50=1 μM). GSK-25 inhibits P450 profile (IC50s of 2.5, 5.2, 2.5 µM for CYP2C9, CYP2D6, CYP3A4, respectively) .
loading...
    loading...
Cat. No.: HY-B1914
CAS No.: 119168-77-3
Tebufenpyrad can induce mitochondrial dysfunction and oxidative damage. Tebufenpyrad induces dose-dependent cell death on N27 cells, with an EC50 value of 3.98 μM .
loading...
    loading...
Cat. No.: HY-176239
Research Areas:  

Cancer

PROTAC PI3Kδ degrader-1 is a Lysine-targeted covalent PI3Kδ PROTAC degrader with a DC50 of 3.98 nM. PROTAC PI3Kδ degrader-1 has a potent antiproliferative activity and selective PI3Kδ inhibition (IC50: 8 nM). PROTAC PI3Kδ degrader-1 also significantly degrades p-AKT, induces cell cycle arrest in G1 phase and prompts cell apoptosis and autophagy. PROTAC PI3Kδ degrader-1 effectively inhibits the tumor growth in SU-DHL-6 xenograft mice model .
loading...
    loading...
Cat. No.: HY-146710
CAS No.: 2259657-48-0
Target:  

RET

Research Areas:  

Cancer

RET-IN-16 is a potent and selective RET inhibitor with IC50s of 3.98 nM, 8.42 nM, 15.05 nM, 7.86 nM, 5.43 nM and 8.86 nM for RET(WT), RET(M918T), RET(V804L), RET(V804M), RET-CCDC6 and RET-KIF5B, respectively. RET-IN-16 has anticancer effects .
loading...
    loading...